Market open
Leap Therapeutics Inc./$LPTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Leap Therapeutics Inc.
Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.
Ticker
$LPTX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
52
Website
LPTX Metrics
BasicAdvanced
$16M
-
-$1.81
0.34
-
Price and volume
Market cap
$16M
Beta
0.34
52-week high
$0.65
52-week low
$0.22
Average daily volume
4.1M
Financial strength
Current ratio
3.413
Quick ratio
3.407
Total debt to equity
0.759
Management effectiveness
Return on assets (TTM)
-71.81%
Return on equity (TTM)
-142.43%
Valuation
Price to book
0.43
Price to tangible book (TTM)
0.43
Price to free cash flow (TTM)
-0.245
Growth
Earnings per share change (TTM)
-54.51%
3-year earnings per share growth (CAGR)
-27.37%
LPTX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Leap Therapeutics Inc. stock?
Leap Therapeutics Inc. (LPTX) has a market cap of $16M as of April 25, 2025.
What is the P/E ratio for Leap Therapeutics Inc. stock?
The price to earnings (P/E) ratio for Leap Therapeutics Inc. (LPTX) stock is 0 as of April 25, 2025.
Does Leap Therapeutics Inc. stock pay dividends?
No, Leap Therapeutics Inc. (LPTX) stock does not pay dividends to its shareholders as of April 25, 2025.
When is the next Leap Therapeutics Inc. dividend payment date?
Leap Therapeutics Inc. (LPTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Leap Therapeutics Inc.?
Leap Therapeutics Inc. (LPTX) has a beta rating of 0.34. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
